Cullinan Management logo
Cullinan Management CGEM
€ 8.10 -2.73%
report update icon

Quartalsbericht 2026-Q3
hinzugefügt 10.11.2026

Cullinan Management ROCE | CGEM

ROCE Jährlich Cullinan Management

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-58.85 -33.31 -41.92 26.86 -15.99 -12.68 -22.74 -43.78 - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
26.86 -58.85 -25.3

ROCE Vierteljährlich Cullinan Management

2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-64.4 -58.09 -55.77 -51.13 -46.98 -42.43 -34.64 -34.74 -35.4 -37.24 -37.12 -39.9 -35.98 -31.42 15.67 20.73 18.71 19.63 -23.59 -15.53 -13.23 -16.2 -15.37 -15.66 -5.78 -7.1 -2.78 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
20.73 -64.4 -23.92

ROCE anderer Aktien in der Pharmaeinzelhändler

Name ROCE Preis % 24h Marktkapitalisierung Land
Annexon Annexon
ANNX
-92.11 $ 3.11 -8.94 % $ 482 M usaUSA
Acasti Pharma Acasti Pharma
ACST
-17.17 - 4.01 % $ 150 M canadaCanada
Aptose Biosciences Aptose Biosciences
APTO
-46.69 - -45.71 % $ 1.2 M canadaCanada
Galapagos NV Galapagos NV
GLPG
9.07 - - $ 1.83 B belgiumBelgium
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
-5.84 - -4.36 % $ 27 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
-168.29 - -52.27 % $ 4.45 M usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
-68.09 $ 4.63 21.05 % $ 20 M israelIsrael
Achieve Life Sciences Achieve Life Sciences
ACHV
-90.77 $ 6.78 0.89 % $ 296 M usaUSA
Leap Therapeutics Leap Therapeutics
LPTX
-25.89 - 368.57 % $ 41.9 M usaUSA
Lumos Pharma Lumos Pharma
LUMO
-134.09 - - $ 35.3 M usaUSA
Gamida Cell Ltd. Gamida Cell Ltd.
GMDA
-46.52 - -18.25 % $ 5.04 M israelIsrael
Axcella Health Axcella Health
AXLA
-1610.96 - -16.42 % $ 249 M usaUSA
Metacrine Metacrine
MTCR
-106.49 - - $ 24.2 M usaUSA
Zealand Pharma A/S Zealand Pharma A/S
ZEAL
-60.71 - 0.52 % $ 821 M danmarkDanmark
Myovant Sciences Ltd. Myovant Sciences Ltd.
MYOV
-69.47 - -0.04 % $ 2.62 B usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
-883.35 - -74.18 % $ 955 K usaUSA
Idera Pharmaceuticals Idera Pharmaceuticals
IDRA
-235.23 - -23.04 % $ 26.6 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
-36.31 - - $ 3.67 B usaUSA
Verona Pharma plc Verona Pharma plc
VRNA
-35.83 - - $ 69.7 B britainBritain
Atreca Atreca
BCEL
-34.9 - -11.76 % $ 5.79 M usaUSA
Guardion Health Sciences Guardion Health Sciences
GHSI
-53.23 - -0.31 % $ 3.64 M usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
11.01 - - $ 109 M usaUSA
Akouos Akouos
AKUS
-37.16 - 0.23 % $ 488 M usaUSA
ImmunoGen ImmunoGen
IMGN
-141.76 - - $ 7.92 B usaUSA
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
VBLT
-96.98 - -8.77 % $ 12.4 M israelIsrael
Cidara Therapeutics Cidara Therapeutics
CDTX
-106.57 - - $ 1.41 B usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
458.12 - - $ 591 K irlandaIrlanda
Virpax Pharmaceuticals Virpax Pharmaceuticals
VRPX
1322.0 - -45.12 % $ 2.85 M usaUSA
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
166.56 - -2.99 % $ 2.47 M usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
102.23 - - $ 23.9 M usaUSA
OncoSec Medical Incorporated OncoSec Medical Incorporated
ONCS
-242.78 - 31.87 % $ 1.61 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
19.77 - -4.8 % $ 255 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
-70.32 - -0.23 % $ 916 M usaUSA
bluebird bio bluebird bio
BLUE
-194.9 - - $ 546 M usaUSA
Landos Biopharma Landos Biopharma
LABP
-71.49 - 0.58 % $ 144 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
-59.84 - - $ 35.4 M usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
545.12 - -5.16 % $ 5.39 M usaUSA
Sigilon Therapeutics Sigilon Therapeutics
SGTX
-111.56 - - $ 728 M usaUSA
Regulus Therapeutics Regulus Therapeutics
RGLS
-65.26 - - $ 155 M usaUSA
NGM Biopharmaceuticals NGM Biopharmaceuticals
NGM
-101.9 - - $ 127 M usaUSA
Aravive Aravive
ARAV
-664.7 - -13.39 % $ 1.45 M usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
-88.5 - - $ 231 M usaUSA
Crinetics Pharmaceuticals Crinetics Pharmaceuticals
CRNX
-52.09 $ 84.95 0.13 % $ 7.99 B usaUSA
Acer Therapeutics Acer Therapeutics
ACER
146.85 - 2.71 % $ 14 M usaUSA
Gilead Sciences Gilead Sciences
GILD
44.14 $ 166.01 -0.31 % $ 207 B usaUSA
Assembly Biosciences Assembly Biosciences
ASMB
-5.8 $ 22.14 -1.6 % $ 248 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
-0.69 - - $ 2.02 B usaUSA
Turning Point Therapeutics Turning Point Therapeutics
TPTX
-24.94 - -0.13 % $ 3.73 B usaUSA
Orgenesis Orgenesis
ORGS
155.73 - -33.86 % $ 61.2 M usaUSA
TCR2 Therapeutics TCR2 Therapeutics
TCRR
-108.97 - - $ 58.1 M usaUSA